Oracle Reports – Here Are The Numbers

June 12, 2003
Brice Wightman

In economic news, Retail Sales
in May came in at +0.1% vs. +0.0%, Ex-Autos sales came also came in a +0.1% vs.
+0.2%. Lower gasoline sales softened what would have been a 0.4% rise. Business
Inventories for April came in at +0.1% vs. +0.2%. And initial jobless claims
came in – 17,000 to 430,00 or higher than the expected 425K. Lastly, the
four-week moving average rose by 2,250 to 433,750.

The 10-year U.S. Note
was +060 at 120 130.

The dollar was -.13 at
92.89.

Gold was -1.00 at 353.80.

Crude Oil was -0.91 at
31.45.

Volume was
1,526,099,000
on the NYSE and 1,784,138,000 on the Nasdaq.

Market breadth was positive,
with NYSE advancing issues over declining issues by a ratio of 1.18, and up
volume over down volume by a 1.04 ratio. Nasdaq declining issues over advancing
issues at 1.10, and up volume over down volume is at a 1.49 ratio.

Top Dow stocks were:

Stocks in the news:

After the close Oracle
(
ORCL |
Quote |
Chart |
News |
PowerRating)
reported a fourth quarter profit of .16 vs. .12 last year.

Cell Therapeutics
(
CTIC |
Quote |
Chart |
News |
PowerRating)
was higher on big volume after the company announced
that the FDA approved its supplemental new drug application for its acute promyelocthic leukemia drug, Trisenox.

Kinder Morgan
(
KMI |
Quote |
Chart |
News |
PowerRating)
rose after the company more than doubled its annual dividend. Due
to changes in recent tax laws, the company has increased its dividend from $0.60
to $1.60 per share.

Freddie Mac
(
FRE |
Quote |
Chart |
News |
PowerRating)
made a 52-week low after the
company revealed the compensation packages for its former executives. Former
Chairman Leland Brendsel will receive his base salary of $1.18 million for two
years and a pro-rated bonus of $860K. Former president David Glenn will receive
his vested stock.

Heinz
(
HNZ |
Quote |
Chart |
News |
PowerRating) reported fourth-quarter results excluding a
one-time charge of 52 cents a share, missing analysts’ estimates by a penny.
Full-year results matched expectations. Looking forward, the company is
expecting to earn between $2.15 and $2.25, compared to estimates of $2.21.

H&R Block
(
HRB |
Quote |
Chart |
News |
PowerRating) reported fourth-quarter results
excluding a one-time charge of $2.77 a share compared to estimates of $2.83. The
company blamed the weakness on the weak job market which led to fewer tax
filers.

Intermune
(
ITMN |
Quote |
Chart |
News |
PowerRating) issued a revenue warning.
The company cut its revenue estimate for the year to between $135 million – $150
million from $160 – $180 million. Intermune cited weak demand for Actimmune.
Bear Stearns also downgraded the stock from “outperform” to “underperform.”Â
ITMN closed at 16.71, down 8.39.

Medimmune
(
MEDI |
Quote |
Chart |
News |
PowerRating)
fell after UBS
downgraded the stock from “buy” to “neutral” based on valuation. UBS also
believes that the company will receive approval from its FluMist during the
second quarter. MEDI closed down 1.34 at 38.05.

Novellus Systems
(
NVLS |
Quote |
Chart |
News |
PowerRating)
dropped after UBS downgraded the stock from “neutral” to “reduce.” UBS
based the downgrade solely on valuation but lifted its price target to $28.50
from $25. NVLS closed at 36.70, down .61.

Oracle Reports – Here Are The Numbers

BUY THE FEAR, SELL THE GREED

Quick Links

Company Info

Contact

Company Resources